The Numbers That Matter
CME Group converted 58.7% of its $6.1 billion in revenue into free cash flow last year. That's $3.6 billion in actual cash generation. For context, the financials sector A-grade threshold sits at 15%. CME cleared that by 43 percentage points.
The company runs the largest derivatives exchange in the world. Futures and options on interest rates, equities, commodities, currencies. Every contract traded generates a fee. Low marginal costs, high margins, recurring revenue. The business model prints cash.
Operating cash flow hit $3.7 billion. Free cash flow came in at $3.6 billion. That 104.7% cash conversion rate means CME generated more free cash than operating cash, likely from working capital timing. Either way, the cash is real.
How The Grade Works
CME starts with an A base grade. A 58.7% FCF margin in financials puts you at the top of the sector by default.
From there, the modifiers stack up:
**+0.5 for healthy FCF margin with manageable debt.** A 58.7% margin paired with 1.0x debt-to-FCF gives you room to operate. Not stretched, not overleveraged.
**+1.0 for very low debt-to-FCF.** Total debt sits at $3.4 billion. Against $3.6 billion in annual FCF, that's 1.0x. Most companies would kill for that ratio. CME can pay off every dollar of debt in a year if it wanted to.
**+0.5 for consistency.** Five straight positive FCF quarters. The coefficient of variation (standard deviation divided by mean) sits at 0.05. Translation: quarterly FCF barely moves. Q3 2024 printed $973 million. Q1 2025 printed $1.1 billion. The range is tight.
Final grade: A. No debate.
Balance Sheet Reality
Total debt: $3.4 billion. Total cash: $2.9 billion. That leaves $536 million in net debt. At 1.0x FCF, it's irrelevant.
Current ratio sits at 1.01. Barely above water on a technical basis, but exchange businesses don't operate like manufacturers. The asset-light model means you don't need massive current asset buffers. Cash flow covers everything.
Debt-to-equity ratio: 0.13. CME could lever up significantly if it wanted to. It doesn't need to. The cash generation handles capital needs, dividends, and buybacks without strain.
What The Quarters Show
Look at the last five quarters:
- Q3 2024: $973M FCF on $1.6B revenue
- Q4 2024: $992M FCF on $1.5B revenue
- Q1 2025: $1.1B FCF on $1.6B revenue
- Q2 2025: $1.0B FCF on $1.7B revenue
- Q3 2025: $950M FCF on $1.5B revenue
Revenue varies slightly quarter to quarter based on trading volumes. Volatility drives volume, volume drives revenue. But FCF stays in a narrow band regardless. That stability matters more than top-line growth for a business like this.
Year-over-year FCF growth sits at negative 2.4%. Q3 2025 FCF ($950M) versus Q3 2024 FCF ($973M). A slight dip, but within the normal range of quarterly variation. Not a trend, just noise.
The Exchange Advantage
CME owns infrastructure that every derivatives trader needs to use. When interest rates move, equity markets swing, or commodity prices shift, volume flows through CME's platforms. The company doesn't take directional risk. It collects fees regardless of which way the market moves.
That structural position creates pricing power. Competitors exist (ICE, Nasdaq), but CME's liquidity advantage makes it the default choice for most products. Network effects keep it there.
Operating leverage is built in. Adding volume doesn't require proportional cost increases. The platform scales. Revenue grows faster than expenses. FCF margin stays elevated.
What To Watch
Trading volume trends matter. Lower volatility means fewer trades, which pressures revenue. The 2024-2025 period saw relatively stable volumes. If volatility picks up, CME benefits immediately. If markets go quiet for an extended period, revenue growth stalls.
Regulatory risk always lurks in the background. Changes to clearing requirements, margin rules, or transaction taxes could impact profitability. CME navigates this well historically, but it's worth monitoring.
Capital allocation tells you what management thinks about growth. CME returns most free cash flow to shareholders through dividends and buybacks. That makes sense when you're already the dominant player and don't need massive reinvestment. But if acquisition opportunities arise or technology investments accelerate, watch how that balance shifts.
Does It Deserve The A?
Yes. CME earns its grade on fundamentals, not hype. The FCF margin is exceptional. The debt load is minimal. The quarterly consistency is rare. The business model works.
This isn't a growth story. CME won't 10x from here. It's a cash generation machine with a durable competitive position. The A-grade reflects that reality. Stable, profitable, and built to last.
Get our best analysis
Free cash flow insights and stock grades, delivered to your inbox.
Aureus Research
Data-driven analysis grounded in free cash flow fundamentals. Every grade, every insight, backed by real numbers from public financial statements.
More Research
Financials: 16 A-Grades With Five Banks Failing
Payments and exchanges print cash. Big banks bleed it. The split is getting worse.
Financials: Twelve A-Grades Propped Up by Payments
The sector looks healthy on paper. But strip out the payment networks and exchanges, and the numbers tell a different story.
FCF Margin: The One Number That Cuts Through Every Earnings Story
Revenue can be manipulated. Earnings get adjusted. But free cash flow margin tells you exactly how much cash a company generates per dollar of sales — and it's why Realty Income scores 67.8% while MicroStrategy bleeds -4,777%.